服务热线
15339069646服务热线
15339069646| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-TSLP mAbs [Solrikitug Biosimilar] (MABL-5244) | MABL-5244 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Influenza A HA mAbs [Sonavibart Biosimilar] (MABL-5245) | MABL-5245 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL17A;ALB mAbs [Sonelokimab1 Biosimilar] (MABL-5246) | MABL-5246 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-IL17F mAbs [Sonelokimab2 Biosimilar] (MABL-5247) | MABL-5247 | ELISA, FACS, Functional assay, in vivo binding | na, na |
| Anti-CLDN18 mAbs [Sonesitatug Biosimilar] (MABL-5248) | MABL-5248 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGFR-1 mAbs [Sotiburafusp Biosimilar] (MABL-5249) | MABL-5249 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Sotigalimab Biosimilar] (MABL-5250) | MABL-5250 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CLU mAbs [Sotevtamab Biosimilar] (MABL-5251) | MABL-5251 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Sotrovimab Biosimilar] (MABL-5252) | MABL-5252 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CTLA4/CD152 mAbs [Sovipostobart Biosimilar] (MABL-5253) | MABL-5253 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Spartalizumab Biosimilar] (MABL-5254) | MABL-5254 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL36RN mAbs [Spesolimab Biosimilar] (MABL-5255) | MABL-5255 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IAP/CD47;CLDN18 mAbs [Spevatamig Biosimilar] (MABL-5256) | MABL-5256 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-MSTN/GDF8/GDF-8/GDF8 mAbs [Stamulumab Biosimilar] (MABL-5257) | MABL-5257 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-IL4R/CD124 mAbs [Stapokibart Biosimilar] (MABL-5258) | MABL-5258 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SIGLEC2/CD22 mAbs [Suciraslimab Biosimilar] (MABL-5259) | MABL-5259 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Sudubrilimab Biosimilar] (MABL-5260) | MABL-5260 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Sugemalimab Biosimilar] (MABL-5261) | MABL-5261 | ELISA, FACS, Functional assay, in vivo binding | G4, Lambda |
| Anti-HAVCR2/TIM3 mAbs [Sabatolimab Biosimilar] (MABL-5201) | MABL-5201 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDCD1/CD279/PD1;HAVCR2/TIM3 mAbs [Sabestomig Biosimilar] (MABL-5202) | MABL-5202 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn